Videos

At the recent European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, Belinda Bardsley (Austin Health, Australia) presented on a research study that assessed the impact...

On September 25, 2022, our co-founder and chief science communicator, Brett Drummond, took to Facebook Live with a very special guest, Dr Travis Stiles (CEO, Novoron Bioscience). Many who follow MStranslate...

While MStranslate has been built upon a desire to report on the latest developments in multiple sclerosis research as they occur, we are also committed to sharing and illuminating the lived experience of MS....

In his first feature as an official member of the MStranslate team, Novoron Bioscience CEO, Dr Travis Stiles, recently sat down with our co-founder, Brett Drummond, to discuss the latest developments in...

Due to the ongoing challenges and restrictions of the COVID-19 pandemic, ECTRIMS Congress 2021 was once again held as a virtual conference this year.  Taking place between October 13 and 15, this meeting...

This week, we premiered our first collaborative project with RealTalk MS, an interview co-hosted by Brett Drummond and Jon Strum. Their very special guest for this inaugural event was Prof Rhonda Voskuhl...

In 2021, the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum was set to take place in Phoenix, Arizona, between February 25th to 27th.  However, due to the coronavirus...

Recently published research from the University Medical Center of the Johannes Gutenberg University has looked at the use of an mRNA vaccine as a potential treatment for multiple sclerosis. In this below...

To mark World Multiple Sclerosis Day on May 30, 2020, our co-founder, Brett Drummond, conducted an in-depth video call with friend and Novoron Bioscience CEO, Dr Travis Stiles, in San Diego. Their conversation...

Research Summary: Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis A German study involving 901 people living with early multiple sclerosis (MS) has found...